Category: Omicron
Sardinia: XJ recombinant is at ~20% of sequences, XM at ~15%
In Sardinia, XJ and XM Omicron recombinants are at 19.67% and 14.75% of sequences respectively. More...
Europe: BA.4 and BA.5 reclassified as Variants of Concern
The European Centre for Disease Prevention and Control has issued an Epidemiological update on 13th May 2022. More...
North Korea: 350,000 Covid cases in two weeks *1 update*
North Korea reported the first death from COVID-19 today and said more than 350,000 people got fever* since late April as COVID-19 “explosively spread nationwide.” More...
Japan: Ties between Omicron variant and severe hepatitis in children
Infection with the Omicron variant of COVID-19 may have a role in recent cases of severe acute hepatitis in children, according to new research presented at a health ministry panel meeting Wednesday 11th May 2022. More...
UK: 1,880 cases of XE Covid recombinant sequenced
The UKHSA have released a new technical briefing outlining the SARS-CoV-2 variants circulating in Britain. More...
North Korea: Total lockdown announced as Omicron BA.2 identified in Pyongyang
North Korea has announced its first ever Covid-19 cases. More...
WHO: China’s zero-Covid strategy is unsustainable *1 update*
China’s flagship zero-Covid strategy to defeat the pandemic is unsustainable, the World Health Organization said Tuesday, adding that it had told Beijing so and called for a policy shift. More...
South Africa: Covid-19 cases, hospitalizations and deaths rise in fifth wave
In a new report out today, an estimation of the current RO number in South Africa was revealed, along with evidence of increasing numbers of cases, hospitalizations and deaths across the country. More...
Vietnam: Severe liver and brain damage in child after Covid-19 infection
A 13-year-old boy just recovered from Covid-19 suddenly returned to fever, red skin, red eyes, the doctor diagnosed multi-system inflammatory syndrome, brain damage. More...
Italy: BA.4 detected in Lombardy
The BA.4 variant, the new Omicron sub-variant under consideration by the World Health Organization (WHO), has been genotyped in Monza, Lombardy. More...